VB
Vesalius Biocapital
Vesalius Biocapital is a Series A to Series C stage investment firm. It has made 22 investments. Average disclosed round size is $17.1M (across 10 rounds with reported amounts).
Portfolio
22
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Alain Parthoens
Managing Partner
Christian Schneider, PhD
Managing Partner
Gaston Matthyssens, PhD
Managing Partner
Stephane Verdood
Managing Partner
Guy Geldhof
Partner
CS
Christian Schneider
Managing Partner
FR
Fabienne Roussel
Partner
DC
David Cristina
Principal
JR
Jean-Christophe Renondin
Senior Investment Manager
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nutrium | Series A | $12M | Sep 2025 |
 Enyo Pharma | Series C | — | Jun 2025 |
| Nutrium | Series A | $12M | Jan 2025 |
 Nutrium | Series A | $12M | Jan 2025 |
| MMemo Therapeutics AG | Series C | — | May 2024 |
| MMemo Therapeutics AG | Series C | — | Nov 2023 |
 Scenic Biotech BV | Series A | $31M | Mar 2022 |
| RRejuvenate Biomed | Series B | — | Oct 2021 |
 Sword | Series B | — | Feb 2021 |
| Sword | Series A | $9M | Feb 2020 |
| RRejuvenate Biomed | Series B | — | Jan 2018 |
| AApitope | Series B | — | Sep 2015 |
 Genkyotex | Series D | — | Jan 2015 |
 Complix | Series B | — | Jun 2013 |
| Genkyotex | Series C | $26M | Jul 2012 |
| TTrinean | Unknown | $3.5M | Jan 2012 |
| PPromethera | Series B | — | Jan 2012 |
| AAmakem | Series A | — | Sep 2011 |
 Activaero | Series A | $5M | Feb 2011 |
| Complix | Series A | — | Jan 2011 |
| Complix | Series A | — | Jan 2010 |
| PPromethera Biosciences | Series A | — | Oct 2009 |
| PPromethera | Series C | — | Jan 2009 |
| TTrinean | Unknown | $3.5M | Jan 2008 |
| AApitope | Series A | — | Jan 2008 |
Page 1 of 2
Top Co-Investors
Andera Partners5 shared
Khosla Ventures3 shared
PMV3 shared
Indico Capital Partners3 shared
Lince Capital3 shared
Portugal Ventures3 shared
High-Tech Gründerfonds3 shared
Green Innovations2 shared
Founders Fund2 shared
Faber2 shared
Vi Partners2 shared
e& capital2 shared
Schroders Capital2 shared
Swisscanto Private Equity2 shared
Verve Ventures2 shared
Pureos Bioventures2 shared
Idinvest Partners2 shared
Forbion2 shared
ITOCHU Corporation2 shared
Last updated: 20 October 2026